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1. Introduction 
Calpains, or the intracellular Ca2+-dependent proteases (EC 3.4.22.17, family C2, cysteine 
protease clan CA) are one of the most important proteolytic systems in cytosol of eukaryotic 
and some prokaryotic cells (reviews: Croall & DeMartino, 1991; Goll et al., 2003; Sorimachi et 
al., 2011a). Calpain family is ancient and diverse since highly variable modules flanking 
conservative proteolytic core are found in the structure of these proteins. Linking of protease 
catalytic domain with ancillary domains, i.e. specialized functional modules with their own 
spectrum of non-proteolytic activities and binding partners, expands calpain functions on 
multiple cellular processes. Calpains are processing proteases cleaving their specific substrates 
at one or a limited number of sites to modulate their structure and activity rather than degrade 
it. Calpains are versatile proteases that have been implicated in diverse cellular signaling 
pathways mediated by calcium, such as cytoskeleton remodeling, cell-cycle regulation, 
differentiation, and death (Croall & DeMartino, 1991; Carafoli & Molinari, 1998; Goll et al., 
2003; Nemova et al., 2010). Calpains were also considered to participate in chromosome 
rearrangements during mitosis (Schollmeyer, 1988), microtubule assembly and disassembly 
(Billger et al., 1988), intracellular signaling, motility, and vesicle traffic (Choi et al., 1997; 
Huttenlocher et al., 1997; Lu et al., 2002; Li & Iyengar, 2002). In mammals and plants it is clear 
that calpains are of critical importance for development (Wang et al., 2003; Dutt et al., 2006; 
Sorimachi et al., 2010). Furthermore, impaired calpain activity due to mutations or 
misregulation of the calpains has been implicated in a variety of pathological conditions 
including muscular dystrophy, ischemia, diabetes mellitus, cancer, and neurodegenerative 
disease (Tidball & Spencer, 2000; Huang & Wang, 2001; Crocker et al., 2003; Mamoune et al., 
2003; Suzuki et al., 2004; Zatz & Starling, 2005). Calpains have attracted much attention 
because of the recent discovery of correlations between calpain gene mutations and human 
diseases, together with elucidation of its three-dimensional structure (Hosfield et al., 1999; 
Strobl et al., 2000) and Ca2+-induced activation mechanisms (Moldoveanu et al., 2002; 2004). 
Because the enzyme participates not only in normal intracellular signal transduction cascades 
but also in various pathological states, calpain research has attracted tremendous interest in 
wide areas of life sciences in both basic and clinical terms.  
2. Distribution and diversity of calpains 
A variety of identified sequences of calpains and calpain-like polypeptides was found in all 
eukaryotes and a few bacteria since 1964 when the first protein of this family (later named 
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m-calpain) was isolated by Gordon Guroff from the rat brain (Guroff, 1964). m-Calpain and 
its close homologue μ-calpain (60% amino acid identity) were discovered prior to other 
calpains and serve as typical family members though possess very distinct features 
compared to other calpains. Firstly, μ- and m-calpains form heterodimers consisting of 
distinct catalytiс subunit (calpain 1 or calpain 2 encoded by CAPN1 or CAPN2, respectively) 
with approximate molecular weight 80 kDa and common regulator polypeptide CSS 
(calpain small subunit) with approximate molecular weight 28 kDa. Isolated calpains 1 and 
2 possess full protease activity of original heterodimers if properly folded (Barrett et al., 
1998). Secondly, μ- and m-calpains are highly susceptible to endogenic proteinaceous 
inhibitor, calpastatin, whereas the majority of calpains exist and function as monomeric 
calpastatin-insensitive proteins. The terms µ-calpain and m-calpain were first used in 1989 
(Cong et al., 1989) to refer to the micromolar Ca2+-requiring (µ-calpain) and millimolar Ca2+-
requiring (m-calpain) proteases, respectively. 
Advances of the last few decades in the field of DNA cloning and sequencing led to 
identification of 895 calpain-coding sequences in wide range of organisms – from bacteria to 
human (according to MEROPS database that provides a comprehensive catalogue and 
structure-based classification of proteases and inhibitors) (Rawlings et al., 2010). Fifteen 
molecules in mammals, 4 in Drosophila melanogaster, 7 in Anopheles gambiae, 14 in 
Caenorhabditis elegans, 7 in Shistosoma mansoni, up to 24 in protozoan kinetoplastids, 
infusoria, and only one in fungi, plants, and some bacteria share more than 25% identity 
with the catalytic domain of m-calpain. The biochemical, immunological, and functional 
characteristics of the possible members of the calpain family significantly vary. 
2.1 Functional diversity of calpains  
2.1.1 Information from transgenic organisms 
Calpain function has been investigated by both genetic and cell-biological routes (review: 
Sorimachi et al., 2010). To understand the physiological function of calpain, targeted 
deletion, and more recently the conditional deletion of calpain genes have been performed. 
Individual knockout of two calpain genes in mouse, Capn2 and Css1, appeared to be 
preimplantation lethal, demonstrating that the calpain system is essential for early 
embryogenesis (Arthur et al., 2000; Zimmerman et al., 2000; Dutt et al., 2006; Tan et al., 
2006); the function of calpains in development is not yet known, however. The targeted 
deletion of only one of the two “ubiquitous” calpains, Capn1, does not result in embryonic 
death (Azam et al., 2001). Loss of Capn9 in NIH3T3 cells results in a more transformed 
phenotype (Liu et al., 2000), but this gene has not yet been targeted in whole organism yet. 
Targeted deletion of Capn3 in mice produces a model for assessing its specific role in muscle 
function and repair (Duguez et al., 2006; Cohen et al., 2006) as multiple genetic loss-of-
function defects in calpain 3a seem to be a cause of limb-girdle muscular dystrophy type IIa 
in human (Zatz & Starling, 2005; Duguez et al., 2006). 
The importance of calpains in physiology of lower organisms is demonstrated by a variety 
of defects caused by compromised calpain function including deficient sex determination in 
C. elegance, defects in aleurone cell development in plants and alkaline stress susceptibility 
in ascomycete Aspergillus nidulans, lethality of calpain-like polypeptide depletion by RNA 
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interference in procyclic cells of kinetoplastid parasites (reviews: Croall & Ersfeld, 2007; 
Sorimachi et al., 2011b). 
2.1.2 Physiological substrates of calpains 
The calpain superfamily includes a diverse proteases that vary greatly in terms of domain 
structure, expression (see below), and substrate specificity. As such, calpains have been 
implicated in wide range biological processes. Despite wealth of new information, the 
precise physiological function(s) of the calpain system remain poorly defined, although 
many potential substrate proteins have been identified in vivo and in vitro. A large number 
of proteins (over 100 have been reported) are cleaved by the calpains in in vitro assays 
(reviews: Goll et al., 1999; 2003). Many of these protein substrates can be placed in one of 
four general categories: 
a. Cytoskeletal proteins especially those involved in cytoskeletal/plasma membrane interactions 
(actin-binding proteins, microtubule-associated proteins, etc.): adducing, ankyrin, 
caldesmon, cadherin, calponin, catenin, C-protein, desmin, dystrophin, gelsolin, 
filamin/actin-binding protein, MAP1, MAP2, myosin, nebulin, neurofilament proteins, 
NFH, NFM, NFL, protein 4.1a, 4.1b, ǂII-spectrin, ǃ-spectrin, synemin, talin, tau, titin, 
tropomyosin, troponin I, troponin T, tubulin, vimentin, vinculin. 
b. Membrane-associated proteins: growth factor receptors (EGF receptors), adhesion 
molecules (integrin, cadherin, N-CAM), ion transporters (Ca2+-ATPase), etc. 
c. Enzymes, cytosolic or membrane-associated: kinases (protein kinase C, myosin light-chain 
kinase, calcium/calmodulin-dependent protein kinase, doublecortin-like kinase, EGF 
receptor kinase, pp60src, ppFAK125); phosphatases (calcineurin, inositol polyphosphate 
4-phosphatase, protein tyrosine phosphatase 1B); phospholipases (phospholipase C), 
etc.  
d. Others: cytokines (interleukin lǂ), transcription factors (Fos, Jun), lens proteins 
(crystallins), etc. 
Calpains are not specific for certain amino acid residues or sequences but recognize bonds 
between domains. As a consequence, calpains hydrolyze substrate proteins in a limited 
manner, and large fragments retaining intact domains are produced by hydrolysis. Thus 
calpains are regarded as the biomodulators of its substrate proteins (Saido et al., 1994; 
Sorimachi et al., 1997; Carafoli & Molinari, 1998; Sorimachi & Suzuki, 2001; Suzuki et al., 
2004). Not all in vitro calpain substrates are cleaved by calpains in vivo. Certain extracellular 
proteins, such as fibronectin or factor V, are unlikely cleaved by calpains in vivo as the 
enzymes are localized exclusively intracellularly except in diseased or injured tissues.  
2.1.3 Some well-documented and proposed calpain functions 
Wide distribution of the protease family among living organisms indicates evolutionary 
conservation of the essential calpain functions. The physiological cell-based techniques 
show that the calpains system are involved in functions as diverse as cytoskeletal/plasma 
membrane attachments, cell motility, signal transduction by the activation of some signaling 
molecules and assembly of focal adhesions, progression through the cell cycle and 
regulation of gene expression, some apoptotic pathways, and long-term potentiation 
(review: Goll et al., 2003).  
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Modifying integrins, cadherins, and cytoskeletal proteins calpains may contribute to the 
developmental regulation of cell adhesion (Franco & Huttenlocher, 2005; Mellgren et al., 
2009). Some cases of membrane fusion, as in myoblast differentiation (Kwak et al., 1993), 
have also been reported to involve calpain activity. In S. mansoni, calpain may regulate 
surface membrane biogenesis (Sorimachi et al., 1993). A controversial but attractive topic is 
the possible involvement of calpain in cell division (Schollmeyer, 1988) and in long-term 
potentiation (del Cerro et al., 1990; Suzuki et al., 1992). 
Two non-classical calpains, Tra3 and PalB (human orthologs of calpain 5 and calpain 7), 
mediate signal transduction pathways for sex determination in nematodes (Sokol & 
Kuwabara, 2000) and alkaline pH adaptation in fungi (Nozawa et al., 2003), respectively. 
Non-proteolytic calpain homologues with substituted amino acids in classical Cys/His/Asn 
triad or truncated catalytic core domain supposed to be involved in calpain system 
regulation by non-productive substrate binding as well as inhibitor binding. The existence 
of calpains with this structural feature indicates that they have specific non-proteolytic 
functions the nature of that has not been established yet. The non-proteolytic function(s) 
may be extended on proteolytically active homologues as well. 
2.1.4 Pathological implications of calpains 
A number of pathologic conditions have been associated with disturbances of the calpain 
system. Calpain-associated pathologies, so called “calpainopathies”, are related with genetic 
defects in calpain polypeptides as well as with calpain misregulation due to loss of Ca2+ 
homeostasis in cell. 
Mutations in some calpain genes are also linked with diseases such as senile diabetes and 
muscular dystrophy. Disease-related disruptions in CAPN3 gene are linked to loss of 
proteolytic activity of muscle-specific calpain 3a (Zatz & Starling, 2005; Dugues et al., 2006). 
Specific splice variants of CAPN3 occur in the lens of the eye and are linked to the formation 
of cataracts (Shih et al., 2006). Limited proteolysis of crystallins by abnormally activated 
calpain is likely to induce lens protein insolubilization during aging. Variations in the 
CAPN10 gene may be a factor contributing to increased susceptibility to a multifactorial 
disease – type 2 diabetes (Horikawa et al., 2000; Goll et al., 2003; Turner et al., 2005). Calpain 
10 may contribute to stimulated secretion and(or) pancreatic cell death (Johnson et al., 2004; 
Marshall et al., 2005), and thereby be relevant to this disease.  
Calpainopathy appears to be primarily caused by compromised protease activity, rather 
than by damaged structural properties. Calpains are believed to be strongly related to 
certain conditions accompanied by calcium misregulation including neurodegeneration. 
Calpains are involved in long-term potentiation, Alzheimer's disease (Suzuki et al., 1992; 
Saito et al., 1993; Muller et al., 1995) and ischemia (Blomgren et al., 1995; review: Siman et 
al., 1996). Taking into account the absence of brain-specific calpain species ubiquitously 
expressed μ- and(or) m-calpains are involved in brain-specific functions. Neuronal 
degeneration in postischemic brain has been shown to involve the activation of various 
signal transduction-related elements such as excitatory amino acid receptors, protein kinase 
C, μ-calpain, and other Ca2+-dependent enzymes (Schmidt-Kastner & Freund, 1991).  
Besides specific role of tissue-specific calpains in target organs, conventional calpains tend 
to be overactivated in muscular dystrophies, cardiomyopathies, traumatic ischemia, and 
www.intechopen.com
 
Molecular Evolution Within Protease Family C2, or Calpains 
 
123 
lissencephaly, probably due to compromised intracellular Ca2+ homeostasis caused by these 
diseases. These observations suggest that calpains function as the mediators of the 
pathological process, not necessarily as the ultimate destroyers of cells. The involvement of 
calpain in pathological states is of particular clinical interest because it is expected that 
further research may eventually lead to therapeutic applications. 
2.2 Domain architecture of calpains  
2.2.1 Catalytic core  
Calpain domain II is the proteolytic papain-like domain with typical catalytic triade 
Cys/His/Asn (clan CA) (Arthur et al., 1995) (‘CysPc’ or cd00044 in the NCBI conserved 
domain database) that shares however little sequence homology with other cysteine 
proteases, and it is likely that it evolved from a different ancestral gene. Predicted 
subdomain IIa contains active site Cys105, whereas the remainder amino acid residues of 
catalytic triade (His262 and Asn286) are located in subdomain IIb. The crystallographic data 
indicate that the catalytic residues of subdomains IIa and IIb are uncoupled in the absence of 
Ca2+ (distance 10.5 Å) (Hosfield et al., 1999; Strobl et al., 2000), and Ca2+ binding induces 
conformational changes in the full-length molecule, allowing assembly of active site. 
Domain II has affinity to Ca2+ essential for enzyme activity since contain two Ca2+-binding 
sites located in peptide loops (Moldoveanu et al., 2004).  
Due to complex domain structure of calpains with highly divergent N- and C-terminal 
regions flanking conservative catalytic core only catalytic domain II sequence but not 
complete amino acid alignment is used to establish protein homology. The degree of 
similarity that allows assigning a polypeptide to the calpain family has not been determined 
yet. Depending on the molecule, the amino acid identity in domain II region varies from less 
than 30% to more than 75%. For example, recently assigned to family protease from 
prokaryote Porphyromonas gingivalis contains catalytic domain almost equally similar to μ-
calpain on the one hand and papain sequence from the other hand and the enzymatic 
properties of the protease drastically differ from the characteristics of μ- and m-calpains 
(Bourgeau et al., 1992). 
Some family members (calpain 6 and demi-calpain of vertebrates, CALPC of Drosophila, 
some of C. elegance homologues, and numerous calpains of kinetoplastid parasites), seem to 
be catalytically inactive proteases owing to substitutions in specific amino acid residues (one 
or more) that are located in critical active-site regions or constitutively truncated catalytic 
domain.  
2.2.2 Other structural and functional modules 
Several functional domains are found on N- or C-terminus of protease core. Calpain genes 
are the products of evolutional combinations of several ancestral unit genes, that is, genes 
for the C2-like, penta-EF-hand, C2-containing T, SOH, PBH, calpastatin-like, Zn-finger, and 
transmembrane domains. 
A typical member of C2 family, calpain 2 (or the catalytic 80-kDa subunit of m-calpain), is a 
prototype used for designation other polypeptides as calpains. Calpain 2 has classical four-
domain architecture, where domain II is proteolytic (Fig. 1), domain III is C2-like domain 
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and domain IV is Ca2+-binding domain of PEF family. Other сalpain homologues have a 
combination of the “classical” domains and the others listed above. 
 
Fig. 1. Calpain classification based on protein domain structure. Typical calpains are 
composed of four domains (I–IV): I – highly divergent N-terminal prodomain; II – protease 
core domain subdivided on IIa and IIb subdomains; III – C2 domain-like; IV (PEF) – penta-
EFhand-containing domain (see details in the text). Atypical calpains have no classical Ca2+-
binding PEF domain and contain additional functional modules either on C-terminus: C2-L 
– C2 domain-like; T – C2 domain; SOH – SOL-homology domain; or on N-terminus: MIT – 
microtubule-interacting-and-transport motif; Zn – Zn-finger-like domain; TM – 
transmembrane domain.  
Based on the amino acid sequence, calpain 2 consists of four domains (Suzuki, 1990); 
according to the X-ray diffraction analysis data (Hosfield et al., 1999; Strobl et al., 2000), in 
the absence of Ca2+ domain II is subdivided on two subdomains carrying different 
components of catalytic triade (Cys or His/Asn, respectively), and there is a linker region 
between domains III and IV.  
N-terminal domain I is only 18–20 amino acid residues in length and has no sequence 
homology with any known polypeptide. This propeptide region is autolyzed upon 
activation. According to crystallography data, the propeptide does not block sterically the 
active site of the enzyme (Hosfield et al., 1999; Strobl et al., 2000) as it is shown for a most of 
protease zymogens; the activation mechanism for calpains is recognized as calcium-induced 
interdomain autoactivation (Goll et al., 2003; Benyamin, 2006). 
Domain III provides the coupling of the catalytic domain II and the Ca2+-binding domain IV 
and accelerates Ca2+-induced conformational changes (Tompa et al., 2001). The spatial 
organization of domain III is determined by eight antiparallel ǃ-strands. This domain shows 
a functional (but low sequence) resemblance to other Ca2+-regulated proteins such as the 
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conserved domain 2 of protein kinase C, or C2; owing to this fact, calpain domain III is 
assigned as C2-like domain (or C2-L) (Fig. 1). Functionally C2 and the C2-L domains have 
an affinity to Ca2+ and enable to associate with internal membrane phospholipids in Ca2+-
dependent manner (Kawasaki & Kawashima, 1996; Hosfield et al., 1999; Tompa et al., 2001). 
Analysis of domain III amino acid sequence indicates that it includes two potential Ca2+-
binding EF-hand motifs functionally active in the calpain from flat worm S. mansoni but 
apparently not binding Ca2+ in mammalian calpains (Goll et al., 2003). 
The sequence of calpain 2 domain IV represents a distinct module in the protein; it has a 
similarity with calmodulin (24–44% identical residues for human molecules) and contains 
five putative Ca2+-binding EF-hand motifs (Sorimachi & Suzuki, 2001) (Fig. 1) thus classical 
calpains belong to penta-EF-hand (PEF) protein family. In addition several alternative 
mechanisms for binding calcium and associating with membrane phospholipids are found 
throughout the family. Since several substrates have been shown to bind to domain IV 
(Noguchi et al., 1997; Shinozaki et al., 1998), it is likely that this domain is important for 
substrate recognition by calpain. In this case, the function can be assumed by other protein-
interactive domains, such as the C2-containing domain T, and, possibly, the SOH and PBH 
domains (see below). 
SOH domain – conservative C-terminal module with putative substrate-recognition function in 
protein SOL (small optic lobes) of Drosophila or in calpain 15, vertebrate homologue of SOL. 
Zn-fingers motifs localized into N-terminal Zn-finger domain of some calpains, such as SOL 
(Kamei et al., 1998), function as intermolecular interaction modules enabling to bind DNA, 
RNA, proteins or small molecules. 
T-module, or classic C2-domain, shares both structural and functional similarity with 
conserved domain 2 of protein kinase C, or C2. This Ca2+-binding module is associated with 
membranes and involved in signal transduction and transmembrane traffic (Barnes & 
Hodgkin, 1996). 
PBH domain, or MIT (microtubule-interacting and transport) domain, is usually found in 
AAA-ATPases and some proteins lacking ATPase domains, such as PalB from Aspergillus 
(Mugita et al., 1997); it is responsible for the association with microtubules and intracellular 
traffic of molecules. 
Domain IQ found only in calpain 16, or demi-calpain, is responsible for the interaction with 
Ca2+-binding molecule – calmodulin in the absence of their own Ca2+-binding motifs. 
Some calpains from protists contain domain CSTN weakly similar to calpastatin; their role is 
not elucidated yet. 
Transmembrane domain (usually in tandem) was found on N-terminus of plant calpain, or 
phytocalpain, and some ciliate calpains ascribed to constitutive membrane anchoring 
proteins. Although membrane binding is not well substantiated for classical calpains, 
predicted transmembrane segments in phytocalpain and some ciliate calpains suggest an 
evolutionary link between calpain function and membranes. 
Domain IK (K for kinetoplastids) of calpain-like proteins – possesses a high degree of 
sequence conservation in one of two kinetoplastid phyletic branches and contains mainly 
www.intechopen.com
 
Protein Engineering 
 
126 
three consensus motifs: GLLF/Y toward the N-terminus, WAFYNDT in the center, and 
VYPxETE toward the C-terminus; its function is not elucidated yet. Only in IK-containing 
kinetoplastid proteins the acylation motifs are localized. The other kinetoplastid calpain-like 
proteins have domain IH (H for heterogeneous) – N-terminal sequence highly variable in both 
intra- and interspecies comparisons (Ersfeld et al., 2005). 
Critical role in calpain activation and calpain response to Ca2+ signaling play temporary 
interaction or co-localization with cellular membranes (Cong et al., 1989; Gil-Parrado et al., 
2003). Several ancillary domains or even auxiliary non-calpain polypeptides are responsible 
for such interaction: (1) acylated N-terminal region in calpain-like proteins of the 
kinetoplastids L. major and T. brucei allowing association with the cytoplasmic face of 
membranes and lipid rafts and contribution to signal transduction (Tull et al., 2004; Croall & 
Ersfeld, 2007); (2) Gly-clustering (conserved peptide GTAMRILGGVI) located in small 
subunit N-terminal domain and formed a membrane-penetrating ǂ-helical structure 
(Dennison et al., 2005), providing a mechanism for calpains 1 and 2 binding to membranes; 
(3) for many calpains, the C2-L domain III provides an additional or alternative mechanism 
for membrane association via its phospholipid-binding properties. None of the conventional 
calpains is acylated, however, that some of the established in vivo substrates of mammalian 
calpains, the cytoskeletal proteins vinculin, spectrin, ankyrin, and band 4.1, are themselves 
acylated and membrane-associated (Maretzki et al., 1990; Bhatt et al., 2002). 
2.3 Classification of calpains 
Conventionally calpains are subdivided on the basis of domain composition onto two 
classes – typical and atypical and on the basis of polypeptide composition onto monomeric 
and oligomeric proteins. Functionally it is rationally to separate calpains on ubiquitous and 
tissue-specific as well as on constitutively proteolytically active and inactive enzymes.  
2.3.1 Structural classification 
Based on the similarity of the domain organization to that of calpains 1 or 2 and the 
presence of penta-EF-hand motif in domain IV, it is proposed to divide calpains into two 
general classes – typical and atypical. Typical calpains have a C-terminal calmodulin-like 
domain carrying EF-hand motifs lacking in atypical calpains. Atypical calpains further 
subdivided into six groups based on homology in the region of ancillary domains (Fig. 1).  
Typical calpains include fifteen known molecules: (1) ten vertebrate proteins such as calpains 
1-3, 8, 9, 11–14, and μ/m-calpain from chicken and Xenopus, (2) three calpains from 
Drosophila such as CALPA, CALPB, and CALPC, and (3) two trematode proteins Sm-calpain 
from Shistosoma mansoni and Sj-calpain from S. japonicum (reviews: Goll et al., 2003; 
Sorimachi et al., 2011a). The complete amino acid sequences of these proteins are highly 
conservative and folding is described as “classical” four-domain architecture. Some data 
suggest that calpains 12 and 14 have domain IV with degenerative EF-hand motifs that are 
unlikely to bind calcium (Croall & Ersfeld, 2007); thus these molecules could be functionally 
assigned to atypical group. 
The products of vertebrate genes CAPN(5–7), CAPN10, CAPN15, and CAPN16, all calpains 
from C. elegans, plants, fungi, trypanosomes, and S. cerevisiae are atypical calpains lacking 
domain IV with EF-motifs. Despite this, almost all atypical calpains are Ca2+-regulated; most 
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probably the interaction of these enzymes with Ca2+ may involve structures distinct from 
EF-hand motifs such as located in domain III (Hood et al., 2004; Shao et al., 2006; Samanta et 
al., 2007) or some possible cofactors (Goll et al., 2003). Conserved domains found on C-
terminus instead of the calmodulin-like domain IV permits one to divide atypical calpains 
on SOL and PalB subfamilies (Fig. 1); and the latter includes calpains 5, 6, 7 and 10 because 
of structural similarity and evolutionary relation of domains III (C2-L) and T (C2). 
Other criterion for structural classification of calpains is their polypeptide composition. 
While a most of identified calpains are monomeric proteins there are some calpains which 
potentially form hetero- or homooligomers in the native form. So, μ- and m-calpains in vivo 
and in vitro forms heterodimers with 28 kDa polypeptide (calpain small subunit, or CSS1, 
formerly referred as calpain 4) through fifth EF-hand motif in domain IV and similar EF-
hand motif in 28 kDa subunit. It means that this EF-hand fragment does not bind Ca2+ but is 
involved in dimerization instead. Full proteolytic activity of digestive tract-specific calpain 9 
(nCL-4) also requires dimerization with CSS1 (Lee et al., 1999). No other calpains identified 
to date bind small subunit. Presence of CSS1 is of critical importance for calpastatin 
regulation as it provides one of three binding site for effective calpain/inhibitor interaction. 
Stomach-specific calpain 8 (nCL-2) exists in both monomeric and homooligomeric forms, 
but not as a heterodimer with CSS1. The oligomerization occurs through domains other than 
the 5EF-hand domain IV, most probably through domain III, suggesting a novel regulatory 
system for nCL-2 (Hata et al., 2007). Calpain 8 sensitivity to calpastatin suggests effective 
enzyme/inhibitor binding through motifs distinct from those localized in small subunit. 
2.3.2 Classification on the basis of tissue distribution 
In addition to the structural features, vertebrate calpains are independently classified into 
two categories according to their tissue (or organ) distribution: (1) calpains with wide tissue 
distribution, so called “ubiquitous” (human μ-calpain, m-calpain, calpains 5, 7, 10, 13, 15, 16, 
and μ/m-calpain from chicken and Xenopus), and (2) tissue-specific calpains (calpains 3, 6, 8, 
9, 11, 12). The products of genes CAPN1 and CAPN2 are found almost in all tissues of higher 
animals with the exception of erythrocytes possessing only one of two forms: μ-calpain in 
human, μ/m-calpain in avian, and m-calpain in fish (Murakami et al., 1981; Nemova et al., 
2000). Calpains 5, 7, 10, 13, 15, and 16 are widely expressed in tissues. Calpains 3a, 3b, 6, 8, 9, 
11, and 12 are tissue-specific; they are expressed in skeletal muscles, the crystalline lens, 
placenta, smooth muscles, alimentary tract, testis, and hair follicle, respectively (review: Goll 
et al., 2003). In mammalian tissues, mRNA transcripts of calpain 14 have not been found yet. 
2.4 Distributions of calpains in living organisms 
Calpain genes are distributed among all kingdoms of life except archea and viruses. There 
are 895 calpain sequences in studied organisms identified to date according to protease 
database MEROPS (Rawlings et al., 2010). Now 15 calpains are known in human (and in 
almost all vertebrates). Other organisms have far fewer genes coding for calpain-like 
proteins. With few exceptions, most organisms outside the animal kingdom (fungi, plants, 
and bacteria) and a most of protists have only a single calpain gene if any (Sorimachi & 
Suzuki, 2001; Goll et al., 2003) while other cysteine proteases are abundant in lower 
eukaryotes and parasitic protozoa (Sajid & McKerrow, 2002; Mottram et al., 2003). 
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Unexpected variety of calpain genes were shown in a number of parasitic kinetoplastids and 
infusoria. The discovery of this surprisingly large family of calpain-like proteins in lower 
eukaryotes contributes to our understanding of the molecular evolution of this abundant 
protein family. 
2.4.1 Calpains in bacteria 
Proteins homologous to calpains have been detected only in few prokaryotes, whereas 96% 
of bacteria, including Escherichia coli and all archea, have no calpain genes. Trp protease 
from Porphyromonas gingivalis illustrates some of the difficulties encountered when assigning 
molecules to the calpain family on the basis of cDNA-derived amino acid sequence alone. 
Although the predicted amino acid sequence of the P. gingivalis enzyme has 53.1% similarity 
(23.7% identity) to domain IIa/IIb of human µ-calpain, the P. gingivalis enzyme has nearly 
the same homology (22.5% identity) with the amino acid sequence of papain; the expressed 
protease is not inhibited by leupeptin, an inhibitor of the calpains, reveal distinct substrate 
specificity and is inhibited, not activated, by Ca2+ (Bourgeau et al., 1992).  
2.4.2 Calpains in fungi 
Most fungal genomes sequenced have only a single gene for calpain-like proteins, the 
exception being Neurospora crassa, where three genes have been identified (data from 
MEROPS database). Highly modular structure of calpains and calpain-like proteins in lower 
eukaryotes that combines novel and conserved sequence modules suggests that they are 
involved in diverse cellular activities. PalB protein from Aspergillus is an ancestor of the 
most evolutionarily conserved subfamily of calpains with known members in vertebrates 
(human calpain 7, or PalBH), yeasts, fungi, protists, nematodes, and insects (except 
Drosophila), but not in plants. PalBH homologues commonly contain two C-terminal C2-L 
domains in tandem and conserved microtubule-interacting and transport (MIT) motifs at the 
N-terminus.  
2.4.3 Calpains in plants 
Phytocalpain genes encoding a highly conserved, unique plant-specific calpain-like 
molecule (phytocalpain) derive their names from the Zea mays Defective Kernel-1 (DEK1) 
gene, which was the first to be phenotypically characterized and cloned (Becraft et al., 2002; 
Lid et al., 2002). The polypeptide encoded by gene DEK1 consists of C-terminal intracellular 
domain with significant sequence homology to domains IIa/IIb and III of calpains 1 or 2 and 
extended N-terminal region that is predicted to contain 21 transmembrane domains 
interrupted by an extracellular loop and an extended cytoplasmic juxtamembrane region 
showing little homology to other proteins (Lid et al., 2002). Highly conserved homologues of 
DEK1 have been described across the plant kingdom, including basal plants such as 
Physcomitrella. Interestingly, these genes occur in one copy in plant genomes sequenced thus 
far, including that of the model plant Arabidopsis thaliana. Phytocalpain has been shown to 
be essential for the correct development of both an embryonic epidermal cell layer and the 
specialized outer layer of the endosperm (aleurone) during seed development in maize and 
Arabidopsis (Lid et al., 2002; Ahn et al., 2004; Johnson et al., 2005). 
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2.4.4 Calpains in invertebrates 
Based on screening of sequenced or partially sequenced genomes a most of unicellular 
protozoan (Plasmodium falciparum, Theileria annulata, Cryptosporidium parvum, Entamoeba 
histolytica, etc.) has a single copy of calpain-coding gene whereas no calpain-like sequences 
were identified in others (for instance, Giardia lamblia) (review: Croall & Ersfeld, 2007).  
Uniquely within protozoa, some kinetoplastid parasites and the ciliate Tetrahymena 
thermophila display expansion of calpain genes. Fourteen genes encoding calpain-related 
proteins have been identified in Trypanosoma brucei, 17 in Leishmania major, 15 in T. cruzi 
(Ersfeld et al., 2005), and 26 in macronuclear genome of the ciliate T. thermophila (Ersfeld et 
al., 2005; review: Croall & Ersfeld, 2007). The presence of numerous calpain-like proteins, 
exceeding the numbers found in most other organisms including vertebrates, and their 
unique protein architecture point to important trypanosomatid-specific functions of these 
proteins that have not been elucidated yet; however, a number of calpain-like proteins are 
differentially expressed during the life cycle of the parasites (Matthews & Gull, 1994).  
Only atypical calpains are found in lower eukaryotes, including protozoan and fungi, as 
well as in C. elegans, plants, and S. cerevisiae (Sorimachi et al., 2011a), whereas three of four 
Drosophila calpains, four S. mansoni calpains and three A. gambiae calpains are typical. All 
calpains in trypanosome and one typical calpain in Drosophila lack one or more of the 
Cys/His/Asn residues at their catalytic site, so they probably are not proteolytic enzymes. It 
is predicted that proteomes of obligate parasites is enriched by the genes of longer 
conserved proteins of fundamental function (Brocchieri & Karlin, 2005) owing to elimination 
low expressed and poorly conserved genes under no or weak selection (Haigh, 1978). 
Calpain diversity in kinetoplastid parasite genomes emphasizes house-keeping function of 
calpains including non-proteolytic ones.  
Only a few calpain-like molecules isolated from Schistosoma mansoni, Drosophila, and 
crustacean have been enzymatically characterized (reviews: Mykles, 1998; Goll et al., 2003; 
Cantserova et al., 2010; Lysenko et al., n.d.). Some of them such as SOL calpain from 
Drosophila are closely related to mammalian calpains and the others are highly distinct from 
that ones.  
Interestingly, neither calpastatin activity nor a calpastatin-like DNA sequence has yet been 
detected in invertebrates; a search of the Drosophila genome failed to detect a gene 
homologous to calpastatin (Laval & Pascal, 2002). CSS polypeptide is also has not been 
found in invertebrates (Pintér et al., 1992).  
2.4.5 Calpain-calpastatin system in vertebrates 
Today, fifteen calpain genes (CAPN1-3, CAPN5-16) (Table 1) and calpain-related genes such 
as calpastatin (CAST) and calpain small subunite (CSS1 and CSS2) have been identified in 
human genome. Two or more of the three well-characterized members of the calpain system, 
µ-calpain, m-calpain, and calpastatin, has been detected in any vertebrate cell that has been 
carefully examined for their presence. Different tissues (or cells), however, differ widely in 
the ratios of the three proteins (Thompson & Goll, 2000). Other calpains are expressed in 
more or lesser extent in tissue-specific manner. 
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Gene 
Chromos
ome 
Gene 
product 
Other names 
Protease 
activity 
Domains 
Expression 
C2-L C2(T) PEF 
CAPN1 11q13 calpain 1 
μ-calpain large 
subunite 
+ + – + ubiquitous 
CAPN2 1q41-q42 calpain 2 m-calpain large 
subunite 
+ + – + 
ubiquitous 
(except for 
erythrocyte) 
CAPN3 15q15.1-
q21.1 
calpain 3a p94 + + – + skeletal muscle 
calpain 3b Lp82, Lp85 + + – + lens, retina 
calpain 3c  + + – + ubiquitous 
CAPN5 11q14 calpain 5 hTRA-3 + + + – 
ubiquitous 
(abundant in 
testis, brain) 
CAPN6 Xq23 calpain 6 calpamodulin – + + – 
embrionic 
muscles, 
placenta 
CAPN7 3p24 calpain 7 PalBH + ++ – – ubiquitous 
CAPN8 1q41 
calpain 8 nCL-2 + + – + 
gastrointestinal 
tract 
calpain 8b nCL-2’ + – – – 
calpain 8c  + + – +/– 
CAPN9 
1q42.11-
q42.3 
calpain 9 nCL-4 + + – + gastrointestinal 
tract calpain 9b  + + – + 
CAPN10 2q37.3 
calpain 10  + ++ – – 
ubiquitous calpain 10b-
h 
 n.d. +/– – – 
CAPN11 6p12 calpain 11  n.d. + – – testis 
CAPN12 19q13.2 
calpain 12  n.d. + – + 
hair follicle calpain 12b, 
12c 
 n.d. + – +/– 
CAPN13 2p22-p21 calpain 13  n.d. + – + ubiquitous 
CAPN14 
2p23.1-
p21 calpain 14  n.d. + – + ubiquitous 
CAPN15 16p13.3 calpain 15 SOLH n.d. – – – ubiquitous 
CAPN16 6q24.3 calpain 16 demi-calpain – – – – ubiquitous 
Table 1. Some characteristics of human calpains 
Furthermore, several calpain genes from vertebrates (Capn3, Capn8-10, and Capn12) and a 
few calpains from invertebrates (CalpA from Drosophila) possess specific sites for alternative 
splicing. For example, at least eight splice variants of calpain 10 (calpains 10a through 10h) 
have been identified, including three variants that lack intact domain II and thus have no 
protease activity (Horikawa et al., 2000). 
Chickens and Xenopus laevis have been shown to contain μ/m-calpain with intermediate 
structural and enzymatic characteristics between common mammalian calpains and was 
recently shown to correspond to mammalian calpain 11 from an evolutionary viewpoint 
(Sorimachi et al., 1995; Macqueen et al., 2010). Fish due to polyploidization events in nature 
history have a duplicate set of most of the fifteen mammalian calpains and calpain-related 
molecules (Lepage & Bruce, 2008; Macqueen et al., 2010).  
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Only oligomeric molecules of calpains are inhibited by calpastatin; μ- and m-calpains have 
similar susceptibility to calpastatin. Among other homologues only calpains 8 and 9 are also 
inhibited by calpastatin (Lee et al., 1999; Hata et al., 2001; 2007).  
Significantly that higher organisms along with enzymes having “advanced” characteristics 
(dimere structure, tissue-specific patterns of expression, alternative promotors, regulation 
by calpastatin, etc.), contain almost whole set of non-classical calpain homologues 
conservative from lower eukaryotes and invertebrates (Bondareva & Nemova, 2008).  
3. Phylogenetic analysis of calpains  
Phylogenetic trees have been constructed for isolated domains (Sorimachi & Suzuki, 2001; 
Jékely & Friedrich, 1999) and for the defining catalytic core domain II in conjunction with 
the most common auxiliary domain III of selected species (Jékely & Friedrich, 1999; Wang et 
al., 2003). The phylogenetic approach confirms clear segregation of two main groups of 
calpains: the first clade includes EF-hand-containing CAPN genes (Schistosoma, Drosophila 
A/B and the classic vertebrate calpains) and also EF-hand-free C. elegans CLP-1, and the 
second cluster contains capn5(TRA-3) and capn6 typical and atypical (Jékely and Friedrich, 
1999). This segregation clearly corresponds to common groups of typical and atypical 
calpains except for CLP-1 protease. 
Heterodimeric vertebrate calpains (μ- and m-calpains and calpain 9) are grouped together 
with a reliability of 96%, and it is highly probable that calpains of S. mansoni and Drosophila 
also belong to this group. The results of the phylogenetic approach to the study of calpains 
indicate that the scenario of their evolution is similar to that proposed for the evolution of 
other multigene families (actin, troponin, Hox and others) in vertebrates (Holland et al., 
1994; Ohta, 1991). 
3.1 Evolutionary roots of calpains 
For the first time, Koichi Suzuki has suggested in 1987 the hypothesis that calpains are 
chimeric proteins originated by the fusion of two genes coding for proteins with completely 
different functions and origins – cysteine protease and calmodulin (Suzuki et al., 1987). 
Initially it was predicted that the catalytic domain of calpains and other cysteine proteases, 
such as papain and cathepsins B, H, and L, arose from a single archetypical protease. Based 
on this presumption, these enzymes were grouped into a unified family of papain 
peptidases C1. According to the refined structural information calpains were included in the 
database MEROPS (Rawlings et al., 2010) as an individual family C2 of the papain-like clan 
CA of cysteine peptidases. Although common catalytic triade Cys/His/Asn and papain-like 
catalytic mechanism (Arthur et al., 1995) calpains share little sequence homology with other 
cysteine proteases, and it is likely evolved from a different ancestral gene. 
3.2 Possible scenario of molecular evolution in calpain family  
Structural features, together with the organization of mammalian calpain genes, strongly 
suggest that calpains evolved by the arrangement and restructuring of genes of the ancestral 
calpain-type cysteine protease with other functional units. Evolutionary history of calpains 
is a classical example of a multigene protein family evolution. 
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A small-scale or large-scale genome duplication occurred in different lineages generates 
additional new genes, the majority of which (about 70-90%) have since been degraded 
and(or) lost (“nonfunctionalization”). The functions of the ancestral gene may be distributed 
among the duplicates (so called “subfunctionalization”) or one of the duplicates retains the 
ancestral functions while the other acquires a completely new function 
(neofunctionalization) (Braasch & Salzburger, 2009). The gene duplication with subsequent 
divergent resolution, subfunctionalization and neofunctionalization (“duplication-
diversification hypothesis”) is applicable to calpain evolution as well. 
3.2.1 Gene duplication 
Any gene family is the product of gene duplication. The importance of gene duplication in 
molecular evolution is well established (Nei, 1969; Ohno, 1970). Gene copies can be 
generated through one of two main mechanisms, namely small-scale or large-scale 
duplication events, with the most extreme large-scale event being duplication of the entire 
genome (Hakes et al., 2007). 
It has been hypothesized that the highly conserved sequence and protein structures of 
typical calpain family members arose from multiple tandem duplications of a single 
ancestral calpain gene with subsequent functional diversification of copies (Jekely & 
Friedrich, 1999; Hata et al., 2001). The topology of the phylogenetic tree of calpains together 
with the analysis of chromosomal localization of calpain genes shed light on the time of two 
episodes of major calpain gene duplications coinciding with early chordate whole-genome 
duplications (Holland et al., 1994; Jékely & Friedrich, 1999). 
One episode of gene duplication occurred later than the separation of lines plants–animals 
and fungi–animals (Jékely & Friedrich, 1999). This conclusion was made after the detection 
of atypical T-domain-containing calpains 5 and 6 in vertebrates (Mugita et al., 1997; Dear et 
al., 1997), homologous to C. elegans TRA-3, probably, their direct ancestor. Since plants and 
fungi lack TRA-3 homologues and typical EF-hand Ca2+-binding calpains (Wolfe et al., 1989; 
Mewes et al., 1997) it was supposed that the the first round of duplication that led to the 
separation of TRA-3 and typical calpains occurred earlier than the divergence of the lines of 
protostomatic and deuterostomatic animals. The acquisition of conventional domain IV is 
considered a late event in calpain evolution that has occurred during animal evolution but 
not in other eukaryotic branches (Ohno et al., 1984). 
The origination of calpains specific to vertebrates is refered to the second episode of gene 
duplication occurred at early stages of the evolution of chordates. The mapping of the 
human genome showed that 15 calpain genes as well as the gene of the 28 kDa calpain 
subunit are grouped on nine chromosomes: 1, 2, 3, 6, 11, 15, 16, 19, and X (Hata et al., 2001; 
Dear & Boehm, 2001) (Table 1). Tandem chromosomal localization of calpain genes may also 
suggest their coordinated regulation (e.g., through the Ca2+ sensitivity, the involvement of 
common enhancer elements or locus control regions). Proposed gene duplication events 
may explain the closer evolutionary relationships between the pairs CAPN2 and CAPN8, 
CAPN3 and CAPN9, and CAPN1 and chicken μ/m calpain gene (Jékely & Friedrich, 1999). 
The third predicted round of whole genome duplication (also known as the 3R duplication) 
is specific for teleost fish lineage (Hoegg et al., 2004; Hurley et al., 2007; Braasch & 
Salzburger, 2009) and endowed teleosts with additional new genes. Thus, both capn1a and 
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capn1b in fish appear to be orthologous to the single CAPN1 gene and capn2a and capn2b – 
orthologous to calpain 2 present in other vertebrate species. Furthermore, both Css1a and 
Css1b identified in zebrafish exhibit conserved synteny and significant sequence identity to 
human CSS1, whereas only a single CAST orthologue that produces multiple transcript 
variants through alternative splicing has been found in teleost (Lepage & Bruce, 2009). Fish-
specific proteins of calpain system most probably arose from the 3R duplication during 
teleost evolution (Hoegg et al., 2004; Hurley et al., 2007).  
The presence of five calpain-like proteins with three copies of domain II identified in 
kinetoplastids has to be a relatively late gene segment duplication in an ancestral species 
(Ersfeld et al., 2005). 
3.2.2 Gene fusion 
Protein domains are fundamental and largely independent units of protein structure and 
function which occur in a number of different combinations or domain architectures. 
Interestingly, more complex organisms have more complex domain architectures, as well as 
a greater variety of domain combinations (Chothia et al., 2003; Babushok et al., 2007). It has 
been proposed that the novel combinations of preexisting domains had a major role in the 
evolution of protein networks and more complex cellular activities (Pawson & Nash, 2003; 
Peisajovich et al., 2010). 
Fusion of interacting single-function proteins into oligodomain units may facilitate the 
interaction between functional units and diminish the need to produce proteins in greater 
amounts to achieve appropriate concentrations of their complexes in the cell. It seems 
plausible that the acquisition of longer, polyfunctional proteins in eukaryote organisms may 
have evolved concomitant with the acquisition of multi-exon proteins (Brocchieri & Karlin, 
2005). 
Gene duplication has preceded domain gain in at least 80% of the gain events (Buljan et al., 
2010). Genesis of multiple gene variants as a result of small- and large-scale gene 
duplication followed by their fusion, exon deletion, insertion of extended sequences, amino 
acid substitution, etc. are considered as the basis of calpain diversity. Novel domain 
combinations have a major role in evolutionary innovation. Newly formed structures 
underwent functional differentiation and caused the appearance of new morphological and 
cellular characteristics of vertebrates (Ohta, 1991). The major mechanism for gains of new 
domains in metazoan proteins is likely to be gene fusion through joining of exons from 
adjacent genes, possibly mediated by non-allelic homologous recombination (Buljan et al., 
2010).  
Acquisition of the penta-EF-hand module involved in calcium binding (and the formation of 
heterodimers for some calpains) seems to be a relatively late event in calpain evolution. 
Calpain homologues from protozoan, plant, C. elegans, and fungi lack calmodulin-like 
domain, and thus it seems likely that the proposed cysteine protease-calmodulin gene 
fusion leading to the classical calpain structure (Croall & DeMartino, 1991; Goll et al., 2003; 
Sorimachi et al., 2010) occurred exclusively within the animal lineage. Even similar 
functional units such as EF-hand module evolutionary gained by different ways. A 
phylogenetic tree rooted to the calpain-related sequence of the prokaryote Porphyromonas 
gingivalis and based only on the catalytic core suggests that the EF-hand-containing calpains 
from animals (C-terminal EF-hands) and Tetrahymena (N-terminal EF-hands) are 
www.intechopen.com
 
Protein Engineering 
 
134 
phylogenetically well separated (Croall & Ersfeld, 2007). This raises the possibility that the 
acquisition of these motifs occurred through independent gene-fusion events in these groups. 
Transmembrane motif present in calpains from different sources (ciliate Tetrahymena and 
plants). The phylogenetic analysis reveals a close relationship of indicated transmembrane 
motif-containing calpains, thus raising the possibility of a common origin for these unusual 
calpains (Croall & Ersfeld, 2007). Lateral gene transfer from a green alga-type endosymbiont 
of ciliates is one possible mechanism. 
Apart from episodes of gene fusion there are elucidated some episodes of sequence partial 
deletion. Calpain 8 of vertebrates lacks the functional exon 10'. EF-hands module has been 
lost during evolution by some calpain genes. Calmodulin-like domain is absent in the 
structure of calpain CLP-1 from C. elegans but on the basis of phylogenetic analysis it occures 
to belong to EF-hand Ca2+-binding clade (Jékely & Friedrich, 1999); that may suggest that 
this sequence might have lost it calmoduline-like domain secondarily.  
Small subunit of calpains shares homology only with EF-hand-containing domain IV of 
typical calpains. Mamimum-likehood tree resolved the phylogeny of calpain small subunit 
which derived from CAPN3 gene; chromosomal localization of corresponding calpain genes 
strongly supports this hypothesis (Jékely & Friedrich, 1999).  
3.2.3 Divergent evolution of duplicated calpain genes 
The domain structure of calpains was realized during several acts of fusion and duplication 
of genes with subsequent loss of functional exons or residues. It is highly probable that the 
variable C-terminal domains such as the C2-L domain (domain III), the EF-hand-containing 
calmodulin-like domain (domain IV), the TRA-3-homologous domain (or C2 domain, T-
module), PalB-homologous domain (PBH), and SOL-homologous domain (SOH) originated 
from independent sources. 
In splice-variant CAPN3 (muscle-specific calpain 3a) and Drosophila CALPA there are 
unique inserted regions (Pintér et al., 1992). Insertion of extended sequences led to the 
formation of new functional associations and substantionaly changes the characteristics of 
the protein. For example, due to three unique fragments (NS, novel sequence; IS1, insert 1; 
and IS2, insert 2) in the structure of calpain 3a are responsible for high susceptibility to 
autoproteolysis, capability to binding skeletal muscle myofibrils, and nuclear localization 
(Kinbara et al., 1998; Goll et al., 2003). 
Along with mechanisms of protease invention that are based on gene duplication and 
divergence, the evolution of calpains has also been driven by exon shuffling and the 
duplication of protein modules in protease genes to form new architectures. By these 
mechanisms protease substrate and binding specificities can be altered in an evolutionarily 
rapid and selectable way that leads to gene-family diversity and results in substrate 
specificity or diversity and new kinetic, inhibitory, and cell or tissue localization properties 
(Puente et al., 2003). 
3.2.4 Functional diversification of calpains 
Following gene duplication the newly emerging paralogues descendants may undergo 
functional differentiation (Ohta, 1991). Genetic variants of calpains were subjected to further 
functional diversification. 
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Acquired ancillary domains in calpain structure can interact with many subcellular 
organelles and molecules including phospholipids, calmodulin, calpastatin and even with 
each other (that was shown for calpains 8 and 9 and some invertebrate calpains). Structural 
diversity of calpains due to composition of highly conserved catalytic domain with other 
functional modules indicates that calpains are involved in a variety of fundamental 
processes at cellular (for example, motility) and organism (for example, embryogenesis) 
levels. Despite of overlapping or unique substrate specificities and inhibitor sensitivities of 
calpains the studies of their individual functions in cellular pathways have to be designed to 
acheieve their distinguishing. Nevertheless high selectivity and processing mode of their 
action allow considering calpains as intracellular modulator proteases. 
Specific calpain-dependent processes in invertebrates vary from alkaline adaptation in 
Aspergillus (calpain PalB) (Nozawa et al., 2003) to sex determination in nematodes (TRA-3 
from C. elegans) (Sokol & Kuwabara, 2000).  
Both in genetic and cell-biological models on targeted and conditional deletion of CAPN1, 
CAPN2, and CSS1 genes (review: Sorimachi et al., 2010) vital essentiality of calpain 2 in 
embryogenesis of mammals was shown (Dutt et al., 2006). Variable in structure and 
functionality splice variants of CAPN3 gene play tissue-specific roles: calpain 3a in the 
skeletal muscles; calpains Lp82 (or calpain 3b), Lp85, and Lp74 in the crystalline lens; the 
others – in the retina (Rt88, Rt88', and Rt90) and in the cornea (Cn94) of the eye (Fukiage et 
al., 2002). Calpain 3a is essential for skeletal muscle integrity therefore multiple inactivated 
mutations in CAPN3 seem to be a cause of limb-girdle muscular dystrophy type IIa (review: 
Zatz & Starling, 2005). Single nucleotide polymorphism in CAPN10 gene is a hereditary 
factor of high susceptibility to type 2 diabetes (Turner et al., 2005). For calpain 5 (human 
orthologue of TRA-3 from C. elegans) it was proposed analogous role of in mammalian sex 
determination, since the increased expression of the enzyme have been found in testis in 
relation to colon, kidney, liver and trachea and other tissues.  
For the family members lacking key catalytic residues, alternative functions await discovery. 
Inactive homologues found to be abundant in some protease families and might have 
important roles as regulatory or inhibitory molecules, acting as dominant negatives by 
binding substrates through the inactive catalytic or exosite ancillary domains in 
nonproductive complexes, or by titrating inhibitors from the milieu to increase the net 
proteolytic activity (López-Otín & Overall, 2002; Puente et al., 2003; Pils & Schultz, 2004). A 
recent report describes a role for the non-catalytic calpain 6 in the stabilization of 
microtubules (Tonami et al., 2007). The expression of non-protease homologues is 
interesting with an evolutionary viewpoint as the discovery of their physiological functions 
may elucidate calpain functions distinct from proteolysis. It has been argued that non-
proteolytic calpains are derived from catalytic precursors, because the majority of family 
members are active (Todd et al., 2002); however, in kinetoplastids the number of calpain-like 
proteins with a nonstandard catalytic domain far outnumbers the few proteins with the 
classical Cys/His/Asn triad (Ersfeld et al., 2005).  
3.2.5 Evolution of calpain-related genes 
Evolutionary achievements in regulation of calpains implicate the proteins of other families: 
calpastatin, endogenic inhibitor of calpain activity (protease inhibitor family I27), and 
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regulatory small subunit (PEF protein family). In addition to CAPN1 and CAPN2 gene 
products, CSS1, and CAST are regarded as a classic/ubiquitous components of the calpain 
system (Nakamura et al., 1988). 
Calpain small subunit is not essential for protease activity (Yoshizawa et al., 1995; Pal et al., 
2001) but indispensable for correct folding of catalytic subinit (Yoshizawa et al., 1995; 
Moldveanu et al., 2002) primarily acting as a chaperon. CSS1 also plays a role of adaptor 
protein allowing interaction of heterodimer calpains with membranes and consequently 
facilitates their activation. Dissociated CSS1 might have a function different from proteolysis 
after forming a homodimer (Pal et al., 2001); thus, it is required for the induction of 
senescence (Demarchi et al., 2010), Ca2+-dependent repair of wounded plasma membranes 
(Mellgren et al., 2009), and macroautophagy (Demarchi et al., 2006). 
Calpastatin functions as a major inhibitor with high affinity and strict specificity for calpain 
(Suzuki et al., 1987; Maki et al., 1990). Monomeric calpains including calpains 1 and 2 
dissociated from native dimer are not inhibited and thus escape from the regulatory actions 
of calpastatin. Calpastatin displays molecular polymorphism, the biological significance of 
which is not yet understood though it seems to be associated somewhat with cellular 
differentiation (Maki et al., 1990; Lee et al., 1992).  
Described proteins are found only in vertebrates. Thus, both calpain small subunit gene 
CSS1 and calpastatin gene CAST are the “vertebrate genes” (Sorimachi & Suzuki, 2001; 
Cantserova et al., 2010; Lysenko et al., n.d.).  
4. Conclusion 
On the basis of molecular evolution within the calpain protease family there was 
demonstrated how acquisition of structural features facilitates spatial and temporal control 
of the protease activity. Evolutionary achievements developed in the course of calpain 
molecular evolution concern some aspects: (1) regulation of calpain synthesis (alternative 
splicing, tissue-specific patterns of expression), (2) structural characteristics (oligomeric 
structure, specialized functional domains and insertion sequences), (3) enzymatic 
characteristics (limited substrate specificity, increased Ca2+ sensitivity), (4) intracellular 
behavior (additional Ca2+-binding sites, membrane-interacting modules, wide range of 
binding partners), and (5) mechanisms of regulation of their activity (endogenous specific 
inhibitor, calpastatin, activating proteins).  
However calpain study is far for complete and future efforts are needed to determine how 
the modules associated with proteolytic core influence its function. There is likely to be 
interplay between protein-protein interactions, membrane binding, Ca2+ binding and, 
potentially, posttranslational modifications in the modulation of calpain function (Croall 
& Ersfeld, 2007). Many calpain proteins remain to be purified and characterized 
biochemically, so the challenge of identifying their relevant binding partners as well as 
specific functional activity remains. The increased knowledge of the structure, function 
and regulation of proteases will provide excellent opportunities to design new 
generations of therapeutic inhibitors, including those based on endogenous protease 
inhibitors. 
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